Exploiting Tissue Sparing E3 Ligases for Next Generation TPD Medicines

Time: 8:00 am
day: Day 2 AM


  • Highlighting the promises and challenges of exploiting tissue sparing E3 ligases
  • Pinpointing LED selection criteria for novel E3 ligases for TPD application
  • Showcasing tissue sparing E3 ligases to unlock clinically validated targets